How many studies have been conducted on Tumor Necrosis Factor Alpha Induced Protein 3?

BiohacksAI has indexed 196 PubMed studies on Tumor Necrosis Factor Alpha Induced Protein 3. 45% of studies involve human subjects.

What are the main research areas for Tumor Necrosis Factor Alpha Induced Protein 3?

The primary research domains for Tumor Necrosis Factor Alpha Induced Protein 3 are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 196 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Tumor Necrosis Factor Alpha Induced Protein 3

A UBIQUITIN editing enzyme that functions as both a ubiquitin ligase and deubiquitinase. It contains several ZINC FINGERS and functions in the immune response and INFLAMMATION by modulating signals from TNF-ALPHA; IL1-BETA; or pathogens via TOLL-LIKE RECEPTORS to terminate NF-KAPPA B activity.

196+ PubMed studies analyzed · Evidence Score: 51.1

Research Domains

Tumor Necrosis Factor Alpha Induced Protein 3 has been studied across 19 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🦴 Bone & Joint, ⏳ Longevity & Aging. The primary research focus is 🔬 Oncology with 71% of studies addressing this area.

Loading evidence profile...

This evidence profile for Tumor Necrosis Factor Alpha Induced Protein 3 is generated deterministically from 196 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.